M de Jong Selected Research

M de Jong Research Topics

Disease

11	Neoplasms (Cancer) 01/2021 - 01/2000
3	Prostatic Neoplasms (Prostate Cancer) 10/2012 - 06/2009
3	Neoplasm Metastasis (Metastasis) 08/2007 - 10/2000
3	Carcinoid Tumor (Carcinoid) 01/2001 - 08/2000
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2024 - 01/2023
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 10/2000
2	Osteoarthritis 09/2014 - 06/2013
2	Paraganglioma (Paragangliomas) 01/2001 - 10/2000
1	Mood Disorders (Mood Disorder) 04/2024
1	Inflammation (Inflammations) 10/2022
1	Stroke (Strokes) 10/2022
1	Atherosclerotic Plaque (Atheroma) 10/2022
1	Atherosclerosis 10/2019
1	Cardiogenic Shock 02/2018
1	Bone Resorption 09/2014
1	Osteophyte 04/2014
1	Sclerosis 04/2014
1	Lymphatic Metastasis 04/2013
1	Birth Weight (Birth Weights) 01/2012
1	Osteoporosis 01/2011
1	Shock 01/2011
1	Wounds and Injuries (Trauma) 03/2007
1	Thrombosis (Thrombus) 03/2007
1	Proteinuria 09/2005
1	Rectal Neoplasms (Rectal Cancer) 01/2005
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2005
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2003
1	Ewing Sarcoma (Sarcoma, Ewing) 08/2003
1	Neuroblastoma 08/2001
1	Gastrinoma 10/2000
1	Pituitary Neoplasms (Pituitary Adenoma) 10/2000
1	Sarcoidosis (Schaumann Disease) 10/2000
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2000
1	Autoimmune Diseases (Autoimmune Disease) 10/2000
1	Thyroid Neoplasms (Thyroid Cancer) 09/2000
1	Ketosis 02/2000

Drug/Important Bio-Agent (IBA)

7	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2021 - 01/2000
6	Radioisotopes (Radionuclides)IBA 08/2007 - 01/2000
5	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2021 - 01/2000
5	Peptide Receptors (Peptide Receptor)IBA 12/2016 - 01/2000
5	Peptides (Polypeptides)IBA 12/2016 - 01/2000
4	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 08/2003 - 01/2000
3	Hormones (Hormone)IBA 04/2024 - 01/2000
3	RadiopharmaceuticalsIBA 05/2007 - 08/2000
3	Pentetic Acid (DTPA)FDA LinkGeneric 08/2003 - 01/2000
3	Octreotide (Sandostatin)FDA LinkGeneric 12/2001 - 01/2000
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2001
2	Gastrin-Releasing PeptideIBA 12/2016 - 08/2007
2	Bombesin Receptors (Bombesin Receptor)IBA 10/2012 - 07/2011
2	BombesinIBA 07/2011 - 06/2009
2	3-Tyr-octreotideIBA 12/2001 - 06/2001
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 10/2019
1	PapainIBA 09/2014
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 09/2014
1	Tacrolimus (Prograf)FDA LinkGeneric 04/2014
1	Carcinoembryonic AntigenIBA 04/2013
1	GonadotropinsIBA 01/2012
1	Testosterone (Sustanon)FDA Link 01/2012
1	Choline (Choline Chloride)IBA 07/2011
1	methylene diphosphonateIBA 01/2011
1	Technetium (Technetium 99m)IBA 01/2011
1	Anabolic AgentsIBA 01/2011
1	Cytidine Monophosphate (CMP)IBA 08/2007
1	Thrombin FDA Link 03/2007
1	Serum AlbuminIBA 09/2005
1	Enalapril FDA LinkGeneric 09/2005
1	Losartan (Cozaar)FDA LinkGeneric 09/2005
1	SaltsIBA 09/2005
1	Thymidylate SynthaseIBA 01/2005
1	raltitrexed (D 1694)IBA 01/2005
1	NeurotensinIBA 08/2003
1	AcidsIBA 12/2001
1	yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA 12/2001
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 08/2001
1	Tyr(3)- octreotateIBA 06/2001
1	Lanthanoid Series Elements (Lanthanides)IBA 06/2001
1	Taxoids (Taxanes)IBA 10/2000
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2000
1	Cholecystokinin (Pancreozymin)IBA 09/2000
1	Cholecystokinin Receptors (Cholecystokinin Receptor)IBA 09/2000
1	Cholecystokinin B ReceptorIBA 09/2000
1	Nonesterified Fatty Acids (NEFA)IBA 02/2000

Therapy/Procedure

9	Therapeutics 01/2023 - 01/2000
2	Injections 09/2014 - 06/2001
2	Radiotherapy 01/2005 - 10/2000
1	Drug Therapy (Chemotherapy) 01/2023
1	Extracorporeal Membrane Oxygenation 02/2018
1	Radiofrequency Ablation 04/2013
1	Extracorporeal Shockwave Therapy 01/2011
1	Blood Transfusion (Blood Transfusions) 03/2007
1	Chemoradiotherapy 01/2005
1	Intravenous Injections 12/2001